Therapeutic lung lavage in meconium aspiration syndrome: a preliminary report

J Paediatr Child Health. 2007 Jul-Aug;43(7-8):539-45. doi: 10.1111/j.1440-1754.2007.01130.x.

Abstract

Aim: To explore the effects of a large volume lung lavage procedure in ventilated infants with meconium aspiration syndrome.

Methods: Infants with severe meconium aspiration requiring high-frequency ventilation underwent lung lavage using dilute bovine surfactant at a phospholipid concentration of 5 mg/mL. Lavage aliquot volumes were increased through the case series, aiming to deliver two aliquots of 15 mL/kg in rapid sequence. Physiological effects of lavage were documented, and comparison was made with a group of infants with meconium aspiration requiring high-frequency ventilation, in whom lavage was not performed.

Results: Nine episodes of lavage were performed in eight infants at a median age of 23 h (range 8-83 h). Three infants underwent a lavage that was defined as potentially therapeutic (total lavage volume of at least 25 mL/kg administered before 24 h of age). Lavage was not associated with bradycardia or hypotension. Recovery of arterial oxygen saturation to above 80% was achieved within 12 min in all but one infant in whom oxygen saturation was below 80% at the outset. Mean airway pressure was significantly lower in the Therapeutic lavage group compared with non-lavaged infants in the first 48 h, with a trend towards improved oxygenation.

Conclusion: Dilute surfactant lavage with aliquots of up to 15 mL/kg appears to be feasible in haemodynamically stable ventilated infants with meconium aspiration syndrome, and its efficacy deserves further investigation in a randomised controlled trial.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bronchoalveolar Lavage / methods*
  • Cattle
  • Humans
  • Infant, Newborn
  • Meconium Aspiration Syndrome / physiopathology
  • Meconium Aspiration Syndrome / therapy*
  • Pulmonary Surfactants / administration & dosage*
  • Treatment Outcome
  • Ventilators, Mechanical

Substances

  • Pulmonary Surfactants